APEPTICO Forschung und Entwicklung | Date: 2010-10-20
Agency: Cordis | Branch: FP7 | Program: Cooperative | Phase: SME | Award Amount: 1.27M | Year: 2006
Laser machineries have become more and more efficient and precise in the last years and the field of applications today very wide. Nevertheless, on the market there are no laser machineries with high operational flexibility for marking, cutting, engraving and micro-drilling metals. The objective of NOVIGLAS is to realise an innovative laser system that will allow overcoming this limitation. The main innovation of the project regards the diode-pumped solid-state (DPSS) source, based on polycrystalline Nd:YAG (Yittrium Aluminium Garnet doped with Neodymium) ceramics. Respect to mono-crystalline Nd:YAG this material not only can be doped with an higher amount of Nd (5 times more) but can reach better optical and thermal and is easier and less expensive to produce. The particular pumping geometry adopted for the DPSS laser source (edge pumped geometry) allows to reduce the thermal stress on the Nd:YAG material. This allows obtaining an output laser beam matching high power (200 W TEMoo) with high beam quality (M2<5).
APEPTICO Forschung und Entwicklung | Date: 2011-01-12
A cyclic organic compound which comprises 16 amino acids or 17 amino acids and has no carboxyl group C-terminally and/or no amino group N-terminally. Optionally, one of the amino acids is a normatural amino acid. The ring closure is formed between a side chain of one amino acid and the C-terminus of another amino acid, or the ring closure is effected with the aid of a normatural amino acid. A process for producing and using the compound for regulating vectorial ion channels, for treating diseases associated with the lung function and for treating oedemas is provided.
APEPTICO Forschung und Entwicklung | Date: 2011-11-15
Described is a composition comprisinga peptide which consists of 7-17 adjacent amino acids and comprises the hexamer TX
APEPTICO Forschung und Entwicklung | Date: 2013-06-19
What is described is a peptide which consists of 7-20, especially 7-17, adjacent amino acids and comprises the hexamer TX